SOPs for Injectables V 2.0

To lay down a procedure for monitoring and controlling temperature and humidity in sterile and non-sterile manufacturing areas to ensure compliance with cGMP, product stability, and personnel comfort.
Click to read the full article.

This SOP outlines the process for documenting all in-process observations made during the manufacturing of sterile injectable products. Proper documentation ensures product traceability, deviation identification, and compliance with GMP and data integrity standards.
Click to read the full article.

To define a standardized procedure for identifying, monitoring, and ensuring compliance with Critical Process Parameters (CPPs) during the manufacturing of sterile injectable products. Adherence to these parameters is essential to maintain process control, product quality, and compliance with cGMP and regulatory expectations.
Click to read the full article.

To establish a standardized procedure for training manufacturing personnel in in-process monitoring activities to ensure they are competent, understand GMP requirements, and can perform accurate and reliable observations and documentation during sterile injectable production.
Click to read the full article.

To define the standard procedure for planning, conducting, reporting, and following up on internal quality audits in the sterile injectable manufacturing facility. The objective is to verify compliance with GMP, internal procedures, and regulatory requirements, ensuring continuous improvement of quality systems.
Click to read the full article.

To define a structured and systematic approach for preparing Annual Product Quality Review (APQR) reports for all commercial injectable products manufactured at the facility. The purpose of APQR is to evaluate the consistency of the process, detect trends, and identify any opportunities for product or process improvements to ensure continual GMP compliance and product quality.
Click to read the full article.

To establish a systematic procedure for reviewing Quality Control (QC) test results before releasing batches of injectable pharmaceutical products. This ensures that products meet defined specifications and comply with current Good Manufacturing Practices (cGMP), WHO, and ICH guidelines before batch disposition.
Click to read the full article.

To define a systematic approach for identifying, documenting, evaluating, investigating, and resolving deviations in quality assurance (QA) processes associated with sterile injectable manufacturing. This ensures consistent compliance with GMP, WHO, and ICH guidelines and maintains product integrity.
Click to read the full article.

To establish a comprehensive and proactive approach for risk identification, evaluation, mitigation, and control in Quality Assurance (QA) activities. This ensures adherence to GMP and ICH Q9 principles and minimizes the impact of quality risks in sterile injectable manufacturing.
Click to read the full article.

To define a systematic and standardized procedure for performing Root Cause Analysis (RCA) during investigations related to deviations, non-conformances, OOS, OOT, audit findings, and complaints within the sterile injectable manufacturing process.
Click to read the full article.